http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PE-20110367-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-107
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-14
filingDate 2009-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c616320db2c9d12f9af9947557c1e8d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e679b6af42bc00fd40a36fc9d2229c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7bb2dd686f1609e2816c7c2c125ee62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0abd2ff28f9d5280750e89ab0e196ce3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e16aeb51dd14021dccb06e6ede4f102
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e12de1a5a7e8c34aebd4e4d7d17fb53f
publicationDate 2011-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber PE-20110367-A1
titleOfInvention DERIVATIVES OF 4-CYANO-4-PHENYL-PYRROLIDIN-2-CARBOXAMIDES SUBSTITUTED AS INHIBITORS OF THE INTERACTION p53-MDM2
abstract REFERRING TO A CARBOXAMIDE DERIVATIVE OF FORMULA (I), WHERE X IS H, F, Cl, CYANE, NITRO, AMONG OTHERS; AND IT IS H, F, OH, NITRO, AMONG OTHERS; R1 AND R2 ARE C1-C6 ALKYL, C3-C10 CYCLOALKYL, C2-C6 ALKENYL, AMONG OTHERS; R3 H O C1-C6 ALKYL; R4 AND R5 ARE C1-C6 ALKYL, C2-C6 ALKYL, C6-C10 ARYL, AMONG OTHERS; R6 AND R7 ARE (CH2) n-R ', (CH2) n-NR'R ", (CH2) n-NR'COR", AMONG OTHERS; R 'AND R' 'ARE H, C1-C6 ALKYL, C3-C10 CYCLOALKYL, AMONG OTHERS; n IS AN INTEGER FROM 0 TO 6. PREFERRED COMPOUNDS ARE: (2-MORPHOLIN-4-ILETYL) -ACID AMIDE rac- (2R, 3R, 4R, 5S) -3- (3-CHLOROPHENYL) -4- (4 -CHLORO-PHENYL) -4-CYANE-5- (2,2-DIMETHYL-PROPYL) -PYRROLIDINE-2-CARBOXYL, rac- (2S, 3R.4R, 5R) -4- (3-CHLORO-PHENYL) - 3- (4-CHLORO-PHENYL) -2- (2,2-DIMETHYL-PROPYL) -5- [4- (2-MORPHOLIN-4-IL-2-OXO-ETHYL) -PIPERAZINE-1-CARBONYL] - PYRROLIDINE-3-CARBONITRILE, rac- (2S, 3R.4R, 5R) -4- (3-CHLORO-PHENYL) -3- (4-CHLORO-PHENYL) -2- (2,2-DIMETHYL-PROPYL) - 5- [4- (2-OXO-2-PYRROLIDIN-1-IL-ETHYL) -PIPERAZINE-1-CARBONYL] -PYRROLIDINE-3-CARBONITRILE, AMONG OTHERS. IT ALSO REFERS TO A PHARMACEUTICAL COMPOSITION. SUCH COMPOUNDS INHIBIT THE INTERACTION BETWEEN P53 AND MDM2 PROTEINS AND ARE USEFUL IN THE TREATMENT OF CANCER
priorityDate 2008-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559484
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3609161
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10041
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408835962

Total number of triples: 50.